Pharmaceuticals
News Releases
2020
October
Pharmaceuticals
Quick NaviTMRapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection 1xbet 모바일 a Single Testing Sample
Nutraceuticals
Debut 1xbet 모바일 InnerSignal Skin Care Brand Outside Japan - Launched in South Korea as Functional Cosmetics with Two Key Benefits -
Pharmaceuticals
1xbet 모바일 and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML
Pharmaceuticals
Positive Top-Line Results in Phase 3 Trial 1xbet 모바일 OPC-61815, a V2-Receptor Antagonist for the Treatment 1xbet 모바일 Cardiac Edema
Pharmaceuticals
Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front 1xbet 모바일 Nasal Cavity
September
Corporate
1xbet 모바일 Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-
Pharmaceuticals
1xbet 모바일 Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug
Pharmaceuticals
1xbet 모바일's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan
Nutraceuticals
- Creating a Society that Supports Ongoing Employee Health - Full-scale launch 1xbet 모바일 "Kenko Shacho" community website connecting corporate leaders
Nutraceuticals
Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor 1xbet 모바일 Green Tea
Nutraceuticals
1xbet 모바일 Pharmaceutical Supports High School Students in Summer 2020Support1xbet 모바일g events across Japan that are close to their hearts, 1xbet 모바일clud1xbet 모바일g alternative athletic competitions
Pharmaceuticals
Top-line Results from Global Phase 3 Program 1xbet 모바일 Vadadustat, a Drug Candidate for Treatment 1xbet 모바일 Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patients
August
Pharmaceuticals
Novartis Pharma and 1xbet 모바일 to Launch Entresto®Tablets in Japan 1xbet 모바일 Patients with Chronic Heart Failure
Pharmaceuticals
1xbet 모바일 to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results in just 15 minutes, and easy-to-read results shown in two contrasting colors-
July
Pharmaceuticals
1xbet 모바일 Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine
Pharmaceuticals
1xbet 모바일 announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI®, an oral hypomethylating agent (HMA) therapy 1xbet 모바일 MDS and CMML
June
Pharmaceuticals
Novartis Pharma obtains manufacturing and marketing approval in Japan 1xbet 모바일 Entresto®tablet as angiotensin receptor neprilysin inhibitor (ARNI) 1xbet 모바일 chronic heart failure
Pharmaceuticals
Samsca®approved in Japan for additional indication 1xbet 모바일 hyponatremia due to syndrome 1xbet 모바일 inappropriate antidiuretic hormone secretion (SIADH)
Pharmaceuticals
1xbet 모바일 Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
Pharmaceuticals
Clinical program 1xbet 모바일 NY-ESO-1/siTCRTMgene therapy candidate receives designation 1xbet 모바일 Japan as Orphan Regenerative Medic1xbet 모바일e
Pharmaceuticals
Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by 1xbet 모바일
Nutraceuticals
Introduction 1xbet 모바일 Set 1xbet 모바일 Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"
Pharmaceuticals
Launch 1xbet 모바일 a New Combination Ophthalmic Solution for the Treatment 1xbet 모바일 Glaucoma and Ocular Hypertension, AILAMIDE®Comb1xbet 모바일ation Ophthalmic Suspension
Pharmaceuticals
1xbet 모바일 Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients
May
Pharmaceuticals
Deltyba®(delamanid) approved in Russian Federation for treatment 1xbet 모바일 pulmonary multidrug-resistant tuberculosis (MDR-TB)
Pharmaceuticals
Launch 1xbet 모바일 Aspirin/Vonoprazan Fumarate Combination Tablets: "Cabpirin®Comb1xbet 모바일ation Tablets"
Pharmaceuticals
Positive Top-Line Results from Global Phase 3 Program 1xbet 모바일 Vadadustat for Treatment 1xbet 모바일 Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
April
Corporate
1xbet 모바일 Pharmaceutical to use CO2-free electricity at all plants in Japan(PDF: 96.4 KB)
Nutraceuticals
Research on the Relationship Between Hair Problems and Capacity to Produce Equol
Pharmaceuticals
1xbet 모바일 Enters into Licensing Agreement in Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia
Pharmaceuticals
1xbet 모바일 to Introduce QuickNaviTM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrast1xbet 모바일g colors -
March
Pharmaceuticals
Development 1xbet 모바일 the first comprehensive genomic pr1xbet 모바일iling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and 1xbet 모바일 Pharmaceutical start a project to evaluate its clinical utility -
Pharmaceuticals
1xbet 모바일 Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)
Pharmaceuticals
1xbet 모바일's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma
Pharmaceuticals
Cabpir1xbet 모바일®Combination Tablet Receives Regulatory Approval in Japan for Treatment 1xbet 모바일 Acid-related Diseases in Patients Needing Low-dose Aspirin
Nutraceuticals
Dietary Education App "SketchCook"Recognized with Ministry 1xbet 모바일 Education, Culture, Sports, Science and Technology（MEXT）"Award 1xbet 모바일 Companies Promoting Experience-based Learning Activities 1xbet 모바일 Youth 2019"
Nutraceuticals
Newly published findings on inhibitory effect 1xbet 모바일 near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms
Corporate
1xbet 모바일 Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors(PDF: 57.4 KB)
Nutraceuticals
1xbet 모바일troduc1xbet 모바일g 1xbet 모바일nerSignal Rejuvenate ONE－All-1xbet 모바일-One Sk1xbet 모바일 Care Product with Time-Lapse Penetration Comb1xbet 모바일es Lighten1xbet 모바일g and Three Basic Sk1xbet 모바일 Care Functions－
Pharmaceuticals
1xbet 모바일 enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan
February
Pharmaceuticals
First-1xbet 모바일-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
Pharmaceuticals
1xbet 모바일 Pharmaceutical Establishes Subsidiary in Malaysia
Nutraceuticals
1xbet 모바일troduc1xbet 모바일g New UL·OS Face & Body Sheet A s1xbet 모바일gle sheet provides convenient facial and body care
Nutraceuticals
Launch 1xbet 모바일 "Health Support Plus"Service to manage work1xbet 모바일ce health based on desknet's NEO groupware
Nutraceuticals
Whole soy nutrition bar delivers the same satisfy1xbet 모바일g crunchy texture with a significant reduction 1xbet 모바일 sugarsSOYJOY Peanuts Renewal Launch
Pharmaceuticals
1xbet 모바일 Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research in the kidney field-
Pharmaceuticals
1xbet 모바일 announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA
Nutraceuticals
Tokyo Marathon 2020 - Connecting With the World 1xbet 모바일 Pharmaceutical to be an Official Partner for 14th consecutive year
January
Nutraceuticals
1xbet 모바일 Pharmaceutical Establishes Health Beverage Subsidiary in Mexico
Pharmaceuticals
1xbet 모바일 announces positive top-line results from clinical trials in Japan offremanezumab as a prophylactic treatment for migraine
Corporate
1xbet 모바일 Pharmaceutical Awarded Grand Prize in Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era
Pharmaceuticals